instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neoplasm progression'. | Generalized herpes zoster and cutaneous metastasis during chemotherapy for non-small cell lung cancer: A case report.
Although herpes zoster is known to occur in some patients with lung cancer, generalized (disseminated) herpes zoster is an uncommon form whereby hematogenous dissemination of the virus occurs and leads ... | CARBOPLATIN, DOCETAXEL, DURVALUMAB, GIMERACIL\OTERACIL\TEGAFUR, PACLITAXEL | DrugsGivenReaction | CC BY | 33118287 | 18,511,771 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Non-small cell lung cancer stage IIIA'. | Generalized herpes zoster and cutaneous metastasis during chemotherapy for non-small cell lung cancer: A case report.
Although herpes zoster is known to occur in some patients with lung cancer, generalized (disseminated) herpes zoster is an uncommon form whereby hematogenous dissemination of the virus occurs and leads ... | CARBOPLATIN, DOCETAXEL, DURVALUMAB, GIMERACIL\OTERACIL\TEGAFUR, PACLITAXEL | DrugsGivenReaction | CC BY | 33118287 | 18,516,222 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Non-small cell lung cancer'. | Generalized herpes zoster and cutaneous metastasis during chemotherapy for non-small cell lung cancer: A case report.
Although herpes zoster is known to occur in some patients with lung cancer, generalized (disseminated) herpes zoster is an uncommon form whereby hematogenous dissemination of the virus occurs and leads ... | ACYCLOVIR, CARBOPLATIN, GIMERACIL\OTERACIL\TEGAFUR, RADIATION THERAPY | DrugsGivenReaction | CC BY | 33118287 | 18,760,944 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pleural effusion'. | Generalized herpes zoster and cutaneous metastasis during chemotherapy for non-small cell lung cancer: A case report.
Although herpes zoster is known to occur in some patients with lung cancer, generalized (disseminated) herpes zoster is an uncommon form whereby hematogenous dissemination of the virus occurs and leads ... | ACYCLOVIR, CARBOPLATIN, GIMERACIL\OTERACIL\TEGAFUR, RADIATION THERAPY | DrugsGivenReaction | CC BY | 33118287 | 18,760,944 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Generalized herpes zoster and cutaneous metastasis during chemotherapy for non-small cell lung cancer: A case report.
Although herpes zoster is known to occur in some patients with lung cancer, generalized (disseminated) herpes zoster is an uncommon form whereby hematogenous dissemination of the virus occurs and leads ... | CARBOPLATIN, DOCETAXEL, DURVALUMAB, GIMERACIL\OTERACIL\TEGAFUR, PACLITAXEL | DrugsGivenReaction | CC BY | 33118287 | 18,516,222 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Respiratory failure'. | Generalized herpes zoster and cutaneous metastasis during chemotherapy for non-small cell lung cancer: A case report.
Although herpes zoster is known to occur in some patients with lung cancer, generalized (disseminated) herpes zoster is an uncommon form whereby hematogenous dissemination of the virus occurs and leads ... | ACYCLOVIR, CARBOPLATIN, GIMERACIL\OTERACIL\TEGAFUR, RADIATION THERAPY | DrugsGivenReaction | CC BY | 33118287 | 18,760,944 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Skin mass'. | Generalized herpes zoster and cutaneous metastasis during chemotherapy for non-small cell lung cancer: A case report.
Although herpes zoster is known to occur in some patients with lung cancer, generalized (disseminated) herpes zoster is an uncommon form whereby hematogenous dissemination of the virus occurs and leads ... | DOCETAXEL | DrugsGivenReaction | CC BY | 33118287 | 18,485,283 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Viral rash'. | Generalized herpes zoster and cutaneous metastasis during chemotherapy for non-small cell lung cancer: A case report.
Although herpes zoster is known to occur in some patients with lung cancer, generalized (disseminated) herpes zoster is an uncommon form whereby hematogenous dissemination of the virus occurs and leads ... | DOCETAXEL | DrugsGivenReaction | CC BY | 33118287 | 18,485,283 | 2021-01 |
What was the administration route of drug 'ACYCLOVIR'? | Generalized herpes zoster and cutaneous metastasis during chemotherapy for non-small cell lung cancer: A case report.
Although herpes zoster is known to occur in some patients with lung cancer, generalized (disseminated) herpes zoster is an uncommon form whereby hematogenous dissemination of the virus occurs and leads ... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33118287 | 18,760,944 | 2021-01 |
What was the administration route of drug 'VALACYCLOVIR HYDROCHLORIDE'? | Generalized herpes zoster and cutaneous metastasis during chemotherapy for non-small cell lung cancer: A case report.
Although herpes zoster is known to occur in some patients with lung cancer, generalized (disseminated) herpes zoster is an uncommon form whereby hematogenous dissemination of the virus occurs and leads ... | Oral | DrugAdministrationRoute | CC BY | 33118287 | 18,544,968 | 2021-01 |
What was the outcome of reaction 'Condition aggravated'? | Generalized herpes zoster and cutaneous metastasis during chemotherapy for non-small cell lung cancer: A case report.
Although herpes zoster is known to occur in some patients with lung cancer, generalized (disseminated) herpes zoster is an uncommon form whereby hematogenous dissemination of the virus occurs and leads ... | Recovering | ReactionOutcome | CC BY | 33118287 | 18,485,283 | 2021-01 |
What was the outcome of reaction 'Herpes zoster'? | Generalized herpes zoster and cutaneous metastasis during chemotherapy for non-small cell lung cancer: A case report.
Although herpes zoster is known to occur in some patients with lung cancer, generalized (disseminated) herpes zoster is an uncommon form whereby hematogenous dissemination of the virus occurs and leads ... | Recovered | ReactionOutcome | CC BY | 33118287 | 18,516,222 | 2021-01 |
What was the outcome of reaction 'Metastases to skin'? | Generalized herpes zoster and cutaneous metastasis during chemotherapy for non-small cell lung cancer: A case report.
Although herpes zoster is known to occur in some patients with lung cancer, generalized (disseminated) herpes zoster is an uncommon form whereby hematogenous dissemination of the virus occurs and leads ... | Not recovered | ReactionOutcome | CC BY | 33118287 | 18,544,968 | 2021-01 |
What was the outcome of reaction 'Neoplasm progression'? | Generalized herpes zoster and cutaneous metastasis during chemotherapy for non-small cell lung cancer: A case report.
Although herpes zoster is known to occur in some patients with lung cancer, generalized (disseminated) herpes zoster is an uncommon form whereby hematogenous dissemination of the virus occurs and leads ... | Fatal | ReactionOutcome | CC BY | 33118287 | 18,511,771 | 2021-01 |
What was the outcome of reaction 'Non-small cell lung cancer'? | Generalized herpes zoster and cutaneous metastasis during chemotherapy for non-small cell lung cancer: A case report.
Although herpes zoster is known to occur in some patients with lung cancer, generalized (disseminated) herpes zoster is an uncommon form whereby hematogenous dissemination of the virus occurs and leads ... | Fatal | ReactionOutcome | CC BY | 33118287 | 18,760,944 | 2021-01 |
What was the outcome of reaction 'Pleural effusion'? | Generalized herpes zoster and cutaneous metastasis during chemotherapy for non-small cell lung cancer: A case report.
Although herpes zoster is known to occur in some patients with lung cancer, generalized (disseminated) herpes zoster is an uncommon form whereby hematogenous dissemination of the virus occurs and leads ... | Fatal | ReactionOutcome | CC BY | 33118287 | 18,760,944 | 2021-01 |
What was the outcome of reaction 'Respiratory failure'? | Generalized herpes zoster and cutaneous metastasis during chemotherapy for non-small cell lung cancer: A case report.
Although herpes zoster is known to occur in some patients with lung cancer, generalized (disseminated) herpes zoster is an uncommon form whereby hematogenous dissemination of the virus occurs and leads ... | Fatal | ReactionOutcome | CC BY | 33118287 | 18,760,944 | 2021-01 |
What was the outcome of reaction 'Viral rash'? | Generalized herpes zoster and cutaneous metastasis during chemotherapy for non-small cell lung cancer: A case report.
Although herpes zoster is known to occur in some patients with lung cancer, generalized (disseminated) herpes zoster is an uncommon form whereby hematogenous dissemination of the virus occurs and leads ... | Recovering | ReactionOutcome | CC BY | 33118287 | 18,485,283 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Thrombophlebitis'. | Myelopreservation with Trilaciclib in Patients Receiving Topotecan for Small Cell Lung Cancer: Results from a Randomized, Double-Blind, Placebo-Controlled Phase II Study.
Multilineage myelosuppression is an acute toxicity of cytotoxic chemotherapy, resulting in serious complications and dose modifications. Current ther... | TOPOTECAN HYDROCHLORIDE | DrugsGivenReaction | CC BY-NC | 33123968 | 18,528,230 | 2021-01 |
What was the administration route of drug 'TOPOTECAN HYDROCHLORIDE'? | Myelopreservation with Trilaciclib in Patients Receiving Topotecan for Small Cell Lung Cancer: Results from a Randomized, Double-Blind, Placebo-Controlled Phase II Study.
Multilineage myelosuppression is an acute toxicity of cytotoxic chemotherapy, resulting in serious complications and dose modifications. Current ther... | Intravenous drip | DrugAdministrationRoute | CC BY-NC | 33123968 | 18,528,230 | 2021-01 |
What was the dosage of drug 'TOPOTECAN HYDROCHLORIDE'? | Myelopreservation with Trilaciclib in Patients Receiving Topotecan for Small Cell Lung Cancer: Results from a Randomized, Double-Blind, Placebo-Controlled Phase II Study.
Multilineage myelosuppression is an acute toxicity of cytotoxic chemotherapy, resulting in serious complications and dose modifications. Current ther... | 1.5 MG/M2 (ON DAYS 1?5 OF EACH 21-DAY CYCLE) | DrugDosageText | CC BY-NC | 33123968 | 18,528,230 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Maternal exposure during pregnancy'. | Comanagement Strategy Between Academic Institutions and Community Practices to Reduce Induction Mortality in Acute Promyelocytic Leukemia.
Acute promyelocytic leukemia (APL) is a curable leukemia with > 90% survival in clinical trials. Population-based studies from Sweden and US SEER data have shown long-term survival ... | TRETINOIN | DrugsGivenReaction | CC BY-NC-ND | 33125295 | 20,350,168 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Normal newborn'. | Comanagement Strategy Between Academic Institutions and Community Practices to Reduce Induction Mortality in Acute Promyelocytic Leukemia.
Acute promyelocytic leukemia (APL) is a curable leukemia with > 90% survival in clinical trials. Population-based studies from Sweden and US SEER data have shown long-term survival ... | TRETINOIN | DrugsGivenReaction | CC BY-NC-ND | 33125295 | 20,350,168 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Comanagement Strategy Between Academic Institutions and Community Practices to Reduce Induction Mortality in Acute Promyelocytic Leukemia.
Acute promyelocytic leukemia (APL) is a curable leukemia with > 90% survival in clinical trials. Population-based studies from Sweden and US SEER data have shown long-term survival ... | TRETINOIN | DrugsGivenReaction | CC BY-NC-ND | 33125295 | 20,350,168 | 2021-04 |
What was the outcome of reaction 'Maternal exposure during pregnancy'? | Comanagement Strategy Between Academic Institutions and Community Practices to Reduce Induction Mortality in Acute Promyelocytic Leukemia.
Acute promyelocytic leukemia (APL) is a curable leukemia with > 90% survival in clinical trials. Population-based studies from Sweden and US SEER data have shown long-term survival ... | Recovered | ReactionOutcome | CC BY-NC-ND | 33125295 | 20,350,168 | 2021-04 |
What was the outcome of reaction 'Normal newborn'? | Comanagement Strategy Between Academic Institutions and Community Practices to Reduce Induction Mortality in Acute Promyelocytic Leukemia.
Acute promyelocytic leukemia (APL) is a curable leukemia with > 90% survival in clinical trials. Population-based studies from Sweden and US SEER data have shown long-term survival ... | Recovered | ReactionOutcome | CC BY-NC-ND | 33125295 | 20,350,168 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Chronic kidney disease'. | Emphysematous prostatitis: A case report.
We report the case of a 48-year-old man with ischemic stroke, diabetes and chronic renal failure admitted for fever with LUTS associated with nausea and vomiting.The physical examination showed a depressible abdomen, painful prostate on digital rectal examination.A biological i... | CILASTATIN SODIUM\IMIPENEM, CIPROFLOXACIN | DrugsGivenReaction | CC BY-NC-ND | 33134086 | 18,715,495 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Condition aggravated'. | Emphysematous prostatitis: A case report.
We report the case of a 48-year-old man with ischemic stroke, diabetes and chronic renal failure admitted for fever with LUTS associated with nausea and vomiting.The physical examination showed a depressible abdomen, painful prostate on digital rectal examination.A biological i... | CILASTATIN SODIUM\IMIPENEM, CIPROFLOXACIN | DrugsGivenReaction | CC BY-NC-ND | 33134086 | 18,715,495 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Emphysematous prostatitis: A case report.
We report the case of a 48-year-old man with ischemic stroke, diabetes and chronic renal failure admitted for fever with LUTS associated with nausea and vomiting.The physical examination showed a depressible abdomen, painful prostate on digital rectal examination.A biological i... | NOREPINEPHRINE | DrugsGivenReaction | CC BY-NC-ND | 33134086 | 18,694,508 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Metabolic acidosis'. | Emphysematous prostatitis: A case report.
We report the case of a 48-year-old man with ischemic stroke, diabetes and chronic renal failure admitted for fever with LUTS associated with nausea and vomiting.The physical examination showed a depressible abdomen, painful prostate on digital rectal examination.A biological i... | CILASTATIN SODIUM\IMIPENEM, CIPROFLOXACIN | DrugsGivenReaction | CC BY-NC-ND | 33134086 | 18,715,495 | 2021-01 |
What was the administration route of drug 'CIPROFLOXACIN'? | Emphysematous prostatitis: A case report.
We report the case of a 48-year-old man with ischemic stroke, diabetes and chronic renal failure admitted for fever with LUTS associated with nausea and vomiting.The physical examination showed a depressible abdomen, painful prostate on digital rectal examination.A biological i... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 33134086 | 18,776,365 | 2021-01 |
What was the administration route of drug 'IMIPENEM'? | Emphysematous prostatitis: A case report.
We report the case of a 48-year-old man with ischemic stroke, diabetes and chronic renal failure admitted for fever with LUTS associated with nausea and vomiting.The physical examination showed a depressible abdomen, painful prostate on digital rectal examination.A biological i... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC-ND | 33134086 | 18,776,365 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Myelosuppression'. | Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System in Children under the Age of 3 Years.
OBJECTIVE
Atypical teratoid/rhabdoid tumor (ATRT) is a highly aggressive malignancy with peak incidence in children aged less than 3 years. Standard treatment for central nervous system ATRT in children under the age of... | CARBOPLATIN, CISPLATIN, CYCLOPHOSPHAMIDE, ETOPOSIDE, MELPHALAN, VINCRISTINE SULFATE | DrugsGivenReaction | CC BY-NC | 33138347 | 19,979,423 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Venoocclusive liver disease'. | Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System in Children under the Age of 3 Years.
OBJECTIVE
Atypical teratoid/rhabdoid tumor (ATRT) is a highly aggressive malignancy with peak incidence in children aged less than 3 years. Standard treatment for central nervous system ATRT in children under the age of... | CARBOPLATIN, CISPLATIN, CYCLOPHOSPHAMIDE, ETOPOSIDE, IFOSFAMIDE, MELPHALAN, THIOTEPA, VINCRISTINE | DrugsGivenReaction | CC BY-NC | 33138347 | 19,992,879 | 2021-04 |
What was the administration route of drug 'CYTARABINE'? | Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System in Children under the Age of 3 Years.
OBJECTIVE
Atypical teratoid/rhabdoid tumor (ATRT) is a highly aggressive malignancy with peak incidence in children aged less than 3 years. Standard treatment for central nervous system ATRT in children under the age of... | Intrathecal | DrugAdministrationRoute | CC BY-NC | 33138347 | 19,651,900 | 2021-04 |
What was the administration route of drug 'HYDROCORTISONE'? | Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System in Children under the Age of 3 Years.
OBJECTIVE
Atypical teratoid/rhabdoid tumor (ATRT) is a highly aggressive malignancy with peak incidence in children aged less than 3 years. Standard treatment for central nervous system ATRT in children under the age of... | Intrathecal | DrugAdministrationRoute | CC BY-NC | 33138347 | 19,651,900 | 2021-04 |
What was the administration route of drug 'METHOTREXATE SODIUM'? | Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System in Children under the Age of 3 Years.
OBJECTIVE
Atypical teratoid/rhabdoid tumor (ATRT) is a highly aggressive malignancy with peak incidence in children aged less than 3 years. Standard treatment for central nervous system ATRT in children under the age of... | Intrathecal | DrugAdministrationRoute | CC BY-NC | 33138347 | 19,651,900 | 2021-04 |
What was the dosage of drug 'HYDROCORTISONE'? | Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System in Children under the Age of 3 Years.
OBJECTIVE
Atypical teratoid/rhabdoid tumor (ATRT) is a highly aggressive malignancy with peak incidence in children aged less than 3 years. Standard treatment for central nervous system ATRT in children under the age of... | UNK, CYCLIC, ADMINISTERED ON DAY 0 OF EVERY CHEMOTHERAPY CYCLE | DrugDosageText | CC BY-NC | 33138347 | 19,651,900 | 2021-04 |
What was the outcome of reaction 'Sepsis'? | Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System in Children under the Age of 3 Years.
OBJECTIVE
Atypical teratoid/rhabdoid tumor (ATRT) is a highly aggressive malignancy with peak incidence in children aged less than 3 years. Standard treatment for central nervous system ATRT in children under the age of... | Fatal | ReactionOutcome | CC BY-NC | 33138347 | 19,646,488 | 2021-04 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Abdominal distension'. | A Phase II Clinical Trial on the Combination Therapy of PHY906 Plus Capecitabine in Hepatocellular Carcinoma.
A PHY906 and capecitabine combination could be effective as a salvage therapy for patients with hepatocellular carcinoma (HCC) previously treated with multiple systemic therapies. This traditional Chinese medic... | CAPECITABINE | DrugsGivenReaction | CC BY-NC-ND | 33140457 | 18,531,474 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Abdominal pain'. | A Phase II Clinical Trial on the Combination Therapy of PHY906 Plus Capecitabine in Hepatocellular Carcinoma.
A PHY906 and capecitabine combination could be effective as a salvage therapy for patients with hepatocellular carcinoma (HCC) previously treated with multiple systemic therapies. This traditional Chinese medic... | CAPECITABINE | DrugsGivenReaction | CC BY-NC-ND | 33140457 | 18,531,474 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Alanine aminotransferase abnormal'. | A Phase II Clinical Trial on the Combination Therapy of PHY906 Plus Capecitabine in Hepatocellular Carcinoma.
A PHY906 and capecitabine combination could be effective as a salvage therapy for patients with hepatocellular carcinoma (HCC) previously treated with multiple systemic therapies. This traditional Chinese medic... | CAPECITABINE | DrugsGivenReaction | CC BY-NC-ND | 33140457 | 18,531,474 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Aspartate aminotransferase increased'. | A Phase II Clinical Trial on the Combination Therapy of PHY906 Plus Capecitabine in Hepatocellular Carcinoma.
A PHY906 and capecitabine combination could be effective as a salvage therapy for patients with hepatocellular carcinoma (HCC) previously treated with multiple systemic therapies. This traditional Chinese medic... | CAPECITABINE | DrugsGivenReaction | CC BY-NC-ND | 33140457 | 18,531,474 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Decreased appetite'. | A Phase II Clinical Trial on the Combination Therapy of PHY906 Plus Capecitabine in Hepatocellular Carcinoma.
A PHY906 and capecitabine combination could be effective as a salvage therapy for patients with hepatocellular carcinoma (HCC) previously treated with multiple systemic therapies. This traditional Chinese medic... | CAPECITABINE | DrugsGivenReaction | CC BY-NC-ND | 33140457 | 18,531,474 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Diarrhoea'. | A Phase II Clinical Trial on the Combination Therapy of PHY906 Plus Capecitabine in Hepatocellular Carcinoma.
A PHY906 and capecitabine combination could be effective as a salvage therapy for patients with hepatocellular carcinoma (HCC) previously treated with multiple systemic therapies. This traditional Chinese medic... | CAPECITABINE | DrugsGivenReaction | CC BY-NC-ND | 33140457 | 18,531,474 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Dyspnoea'. | A Phase II Clinical Trial on the Combination Therapy of PHY906 Plus Capecitabine in Hepatocellular Carcinoma.
A PHY906 and capecitabine combination could be effective as a salvage therapy for patients with hepatocellular carcinoma (HCC) previously treated with multiple systemic therapies. This traditional Chinese medic... | CAPECITABINE | DrugsGivenReaction | CC BY-NC-ND | 33140457 | 18,531,474 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Granulocytes abnormal'. | A Phase II Clinical Trial on the Combination Therapy of PHY906 Plus Capecitabine in Hepatocellular Carcinoma.
A PHY906 and capecitabine combination could be effective as a salvage therapy for patients with hepatocellular carcinoma (HCC) previously treated with multiple systemic therapies. This traditional Chinese medic... | CAPECITABINE | DrugsGivenReaction | CC BY-NC-ND | 33140457 | 18,531,474 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Haemoglobin abnormal'. | A Phase II Clinical Trial on the Combination Therapy of PHY906 Plus Capecitabine in Hepatocellular Carcinoma.
A PHY906 and capecitabine combination could be effective as a salvage therapy for patients with hepatocellular carcinoma (HCC) previously treated with multiple systemic therapies. This traditional Chinese medic... | CAPECITABINE | DrugsGivenReaction | CC BY-NC-ND | 33140457 | 18,531,474 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hyperbilirubinaemia'. | A Phase II Clinical Trial on the Combination Therapy of PHY906 Plus Capecitabine in Hepatocellular Carcinoma.
A PHY906 and capecitabine combination could be effective as a salvage therapy for patients with hepatocellular carcinoma (HCC) previously treated with multiple systemic therapies. This traditional Chinese medic... | CAPECITABINE | DrugsGivenReaction | CC BY-NC-ND | 33140457 | 18,531,474 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hyponatraemia'. | A Phase II Clinical Trial on the Combination Therapy of PHY906 Plus Capecitabine in Hepatocellular Carcinoma.
A PHY906 and capecitabine combination could be effective as a salvage therapy for patients with hepatocellular carcinoma (HCC) previously treated with multiple systemic therapies. This traditional Chinese medic... | CAPECITABINE | DrugsGivenReaction | CC BY-NC-ND | 33140457 | 18,531,474 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Lymphopenia'. | A Phase II Clinical Trial on the Combination Therapy of PHY906 Plus Capecitabine in Hepatocellular Carcinoma.
A PHY906 and capecitabine combination could be effective as a salvage therapy for patients with hepatocellular carcinoma (HCC) previously treated with multiple systemic therapies. This traditional Chinese medic... | CAPECITABINE | DrugsGivenReaction | CC BY-NC-ND | 33140457 | 18,531,474 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neutrophil count abnormal'. | A Phase II Clinical Trial on the Combination Therapy of PHY906 Plus Capecitabine in Hepatocellular Carcinoma.
A PHY906 and capecitabine combination could be effective as a salvage therapy for patients with hepatocellular carcinoma (HCC) previously treated with multiple systemic therapies. This traditional Chinese medic... | CAPECITABINE | DrugsGivenReaction | CC BY-NC-ND | 33140457 | 18,531,474 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Platelet count abnormal'. | A Phase II Clinical Trial on the Combination Therapy of PHY906 Plus Capecitabine in Hepatocellular Carcinoma.
A PHY906 and capecitabine combination could be effective as a salvage therapy for patients with hepatocellular carcinoma (HCC) previously treated with multiple systemic therapies. This traditional Chinese medic... | CAPECITABINE | DrugsGivenReaction | CC BY-NC-ND | 33140457 | 18,531,474 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'White blood cell disorder'. | A Phase II Clinical Trial on the Combination Therapy of PHY906 Plus Capecitabine in Hepatocellular Carcinoma.
A PHY906 and capecitabine combination could be effective as a salvage therapy for patients with hepatocellular carcinoma (HCC) previously treated with multiple systemic therapies. This traditional Chinese medic... | CAPECITABINE | DrugsGivenReaction | CC BY-NC-ND | 33140457 | 18,531,474 | 2021-03 |
What was the administration route of drug 'CAPECITABINE'? | A Phase II Clinical Trial on the Combination Therapy of PHY906 Plus Capecitabine in Hepatocellular Carcinoma.
A PHY906 and capecitabine combination could be effective as a salvage therapy for patients with hepatocellular carcinoma (HCC) previously treated with multiple systemic therapies. This traditional Chinese medic... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 33140457 | 18,531,474 | 2021-03 |
What was the dosage of drug 'CAPECITABINE'? | A Phase II Clinical Trial on the Combination Therapy of PHY906 Plus Capecitabine in Hepatocellular Carcinoma.
A PHY906 and capecitabine combination could be effective as a salvage therapy for patients with hepatocellular carcinoma (HCC) previously treated with multiple systemic therapies. This traditional Chinese medic... | 14 DAYS ON TREATMENT, DAYS 1 THROUGH 14, AND 7 DAYS OFF TREATMENT | DrugDosageText | CC BY-NC-ND | 33140457 | 18,531,474 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Parkinson^s disease'. | Real-World Virological Efficacy and Safety of Ledipasvir and Sofosbuvir in Patients with Chronic Hepatitis C Virus Genotype 2 Infection: A Multicenter Study.
BACKGROUND
The real-world virological efficacy and safety of interferon-free direct-acting antiviral (DAA) therapy with ledipasvir (LDV) plus sofosbuvir (SOF) wer... | LEDIPASVIR\SOFOSBUVIR | DrugsGivenReaction | CC BY-NC | 33141401 | 18,502,592 | 2021-03 |
What was the administration route of drug 'LEDIPASVIR\SOFOSBUVIR'? | Real-World Virological Efficacy and Safety of Ledipasvir and Sofosbuvir in Patients with Chronic Hepatitis C Virus Genotype 2 Infection: A Multicenter Study.
BACKGROUND
The real-world virological efficacy and safety of interferon-free direct-acting antiviral (DAA) therapy with ledipasvir (LDV) plus sofosbuvir (SOF) wer... | Oral | DrugAdministrationRoute | CC BY-NC | 33141401 | 18,502,592 | 2021-03 |
What was the outcome of reaction 'Parkinson^s disease'? | Real-World Virological Efficacy and Safety of Ledipasvir and Sofosbuvir in Patients with Chronic Hepatitis C Virus Genotype 2 Infection: A Multicenter Study.
BACKGROUND
The real-world virological efficacy and safety of interferon-free direct-acting antiviral (DAA) therapy with ledipasvir (LDV) plus sofosbuvir (SOF) wer... | Recovering | ReactionOutcome | CC BY-NC | 33141401 | 18,502,592 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | An exceptional response to 177LuPSMA undermined by neuroendocrine transformation.
Approximately 25% of patients who have undergone extensive systemic therapy for advanced metastatic castration-resistant prostate cancer (mCRPC) develop treatment associated neuroendocrine prostate cancer (NEPC). 177Lu-prostate specific m... | CABAZITAXEL, CARBOPLATIN, DOCETAXEL, ETOPOSIDE, LUTETIUM CHLORIDE LU-177 | DrugsGivenReaction | CC BY-NC-ND | 33145175 | 19,405,946 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hepatic cancer metastatic'. | An exceptional response to 177LuPSMA undermined by neuroendocrine transformation.
Approximately 25% of patients who have undergone extensive systemic therapy for advanced metastatic castration-resistant prostate cancer (mCRPC) develop treatment associated neuroendocrine prostate cancer (NEPC). 177Lu-prostate specific m... | CABAZITAXEL, CARBOPLATIN, DOCETAXEL, ETOPOSIDE, LUTETIUM CHLORIDE LU-177 | DrugsGivenReaction | CC BY-NC-ND | 33145175 | 19,405,946 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Neuroendocrine carcinoma of prostate'. | An exceptional response to 177LuPSMA undermined by neuroendocrine transformation.
Approximately 25% of patients who have undergone extensive systemic therapy for advanced metastatic castration-resistant prostate cancer (mCRPC) develop treatment associated neuroendocrine prostate cancer (NEPC). 177Lu-prostate specific m... | CABAZITAXEL, CARBOPLATIN, DOCETAXEL, ETOPOSIDE, LUTETIUM CHLORIDE LU-177 | DrugsGivenReaction | CC BY-NC-ND | 33145175 | 19,405,946 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapy non-responder'. | An exceptional response to 177LuPSMA undermined by neuroendocrine transformation.
Approximately 25% of patients who have undergone extensive systemic therapy for advanced metastatic castration-resistant prostate cancer (mCRPC) develop treatment associated neuroendocrine prostate cancer (NEPC). 177Lu-prostate specific m... | CARBOPLATIN, ETOPOSIDE | DrugsGivenReaction | CC BY-NC-ND | 33145175 | 19,432,357 | 2021-01 |
What was the outcome of reaction 'Hepatic cancer metastatic'? | An exceptional response to 177LuPSMA undermined by neuroendocrine transformation.
Approximately 25% of patients who have undergone extensive systemic therapy for advanced metastatic castration-resistant prostate cancer (mCRPC) develop treatment associated neuroendocrine prostate cancer (NEPC). 177Lu-prostate specific m... | Fatal | ReactionOutcome | CC BY-NC-ND | 33145175 | 19,405,946 | 2021-01 |
What was the outcome of reaction 'Hepatic failure'? | An exceptional response to 177LuPSMA undermined by neuroendocrine transformation.
Approximately 25% of patients who have undergone extensive systemic therapy for advanced metastatic castration-resistant prostate cancer (mCRPC) develop treatment associated neuroendocrine prostate cancer (NEPC). 177Lu-prostate specific m... | Fatal | ReactionOutcome | CC BY-NC-ND | 33145175 | 19,432,357 | 2021-01 |
What was the outcome of reaction 'Neuroendocrine carcinoma of prostate'? | An exceptional response to 177LuPSMA undermined by neuroendocrine transformation.
Approximately 25% of patients who have undergone extensive systemic therapy for advanced metastatic castration-resistant prostate cancer (mCRPC) develop treatment associated neuroendocrine prostate cancer (NEPC). 177Lu-prostate specific m... | Fatal | ReactionOutcome | CC BY-NC-ND | 33145175 | 19,405,946 | 2021-01 |
What was the outcome of reaction 'Therapy non-responder'? | An exceptional response to 177LuPSMA undermined by neuroendocrine transformation.
Approximately 25% of patients who have undergone extensive systemic therapy for advanced metastatic castration-resistant prostate cancer (mCRPC) develop treatment associated neuroendocrine prostate cancer (NEPC). 177Lu-prostate specific m... | Fatal | ReactionOutcome | CC BY-NC-ND | 33145175 | 19,432,357 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hepatic enzyme increased'. | Successfully treated bilateral renal fungal balls with continuous Anidulafulgin irrigation.
A 73-year-old man with a history of type 2 diabetes mellitus, nephrolithiasis, and recurrent urinary tract infections caused by Candida glabrata was admitted to our hospital. Urosepsis was diagnosed and C. glabrata was isolated ... | FLUCONAZOLE | DrugsGivenReaction | CC BY-NC-ND | 33145176 | 19,403,378 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Malaise'. | Successfully treated bilateral renal fungal balls with continuous Anidulafulgin irrigation.
A 73-year-old man with a history of type 2 diabetes mellitus, nephrolithiasis, and recurrent urinary tract infections caused by Candida glabrata was admitted to our hospital. Urosepsis was diagnosed and C. glabrata was isolated ... | FLUCONAZOLE | DrugsGivenReaction | CC BY-NC-ND | 33145176 | 19,403,378 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Successfully treated bilateral renal fungal balls with continuous Anidulafulgin irrigation.
A 73-year-old man with a history of type 2 diabetes mellitus, nephrolithiasis, and recurrent urinary tract infections caused by Candida glabrata was admitted to our hospital. Urosepsis was diagnosed and C. glabrata was isolated ... | FLUCONAZOLE | DrugsGivenReaction | CC BY-NC-ND | 33145176 | 19,403,378 | 2021-01 |
What was the administration route of drug 'FLUCONAZOLE'? | Successfully treated bilateral renal fungal balls with continuous Anidulafulgin irrigation.
A 73-year-old man with a history of type 2 diabetes mellitus, nephrolithiasis, and recurrent urinary tract infections caused by Candida glabrata was admitted to our hospital. Urosepsis was diagnosed and C. glabrata was isolated ... | Oral | DrugAdministrationRoute | CC BY-NC-ND | 33145176 | 19,403,378 | 2021-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Atypical neuroimaging characteristics of hemophagocytic lymphohistiocytosis in infants: a case series of hemorrhagic brain lesions in the deep grey matter.
Hemophagocytic lymphohistiocytosis (HLH) is a rare multisystem condition associated with uncontrolled overproduction and infiltration of lymphocytes and histiocytes... | DEXAMETHASONE, ETOPOSIDE | DrugsGivenReaction | CC BY | 33156371 | 19,594,824 | 2021-02 |
What was the outcome of reaction 'Drug ineffective'? | Atypical neuroimaging characteristics of hemophagocytic lymphohistiocytosis in infants: a case series of hemorrhagic brain lesions in the deep grey matter.
Hemophagocytic lymphohistiocytosis (HLH) is a rare multisystem condition associated with uncontrolled overproduction and infiltration of lymphocytes and histiocytes... | Fatal | ReactionOutcome | CC BY | 33156371 | 19,594,824 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Malignant neoplasm progression'. | Structural basis of acquired resistance to selpercatinib and pralsetinib mediated by non-gatekeeper RET mutations.
Selpercatinib (LOXO-292) and pralsetinib (BLU-667) are highly potent RET-selective protein tyrosine kinase inhibitors (TKIs) for treating advanced RET-altered thyroid cancers and non-small-cell lung cancer... | EVEROLIMUS, VANDETANIB | DrugsGivenReaction | CC BY-NC-ND | 33161056 | 19,059,427 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Medullary thyroid cancer'. | Structural basis of acquired resistance to selpercatinib and pralsetinib mediated by non-gatekeeper RET mutations.
Selpercatinib (LOXO-292) and pralsetinib (BLU-667) are highly potent RET-selective protein tyrosine kinase inhibitors (TKIs) for treating advanced RET-altered thyroid cancers and non-small-cell lung cancer... | EVEROLIMUS, VANDETANIB | DrugsGivenReaction | CC BY-NC-ND | 33161056 | 19,059,427 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Structural basis of acquired resistance to selpercatinib and pralsetinib mediated by non-gatekeeper RET mutations.
Selpercatinib (LOXO-292) and pralsetinib (BLU-667) are highly potent RET-selective protein tyrosine kinase inhibitors (TKIs) for treating advanced RET-altered thyroid cancers and non-small-cell lung cancer... | EVEROLIMUS, VANDETANIB | DrugsGivenReaction | CC BY-NC-ND | 33161056 | 19,059,427 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Adenocarcinoma'. | Impella 5.0 supported oncological surgery as bridge to LVAD.
We describe the case of a 58-year-old man presenting with myocardial infarction complicated by cardiogenic shock, treated with Impella CP which was escalated to an axillary 5.0 due to lack of cardiac recovery. Weaning from Impella 5.0 failed, and the patient ... | ASPIRIN, BIVALIRUDIN, THROMBOPLASTIN, TICAGRELOR | DrugsGivenReaction | CC BY-NC | 33161652 | 19,719,802 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Anal ulcer'. | Impella 5.0 supported oncological surgery as bridge to LVAD.
We describe the case of a 58-year-old man presenting with myocardial infarction complicated by cardiogenic shock, treated with Impella CP which was escalated to an axillary 5.0 due to lack of cardiac recovery. Weaning from Impella 5.0 failed, and the patient ... | ASPIRIN, BIVALIRUDIN, THROMBOPLASTIN, TICAGRELOR | DrugsGivenReaction | CC BY-NC | 33161652 | 19,719,802 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Labelled drug-drug interaction medication error'. | Impella 5.0 supported oncological surgery as bridge to LVAD.
We describe the case of a 58-year-old man presenting with myocardial infarction complicated by cardiogenic shock, treated with Impella CP which was escalated to an axillary 5.0 due to lack of cardiac recovery. Weaning from Impella 5.0 failed, and the patient ... | ASPIRIN, BIVALIRUDIN, THROMBOPLASTIN, TICAGRELOR | DrugsGivenReaction | CC BY-NC | 33161652 | 19,719,802 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumonia klebsiella'. | Impella 5.0 supported oncological surgery as bridge to LVAD.
We describe the case of a 58-year-old man presenting with myocardial infarction complicated by cardiogenic shock, treated with Impella CP which was escalated to an axillary 5.0 due to lack of cardiac recovery. Weaning from Impella 5.0 failed, and the patient ... | ASPIRIN, BIVALIRUDIN, THROMBOPLASTIN, TICAGRELOR | DrugsGivenReaction | CC BY-NC | 33161652 | 19,719,802 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Rectal haemorrhage'. | Impella 5.0 supported oncological surgery as bridge to LVAD.
We describe the case of a 58-year-old man presenting with myocardial infarction complicated by cardiogenic shock, treated with Impella CP which was escalated to an axillary 5.0 due to lack of cardiac recovery. Weaning from Impella 5.0 failed, and the patient ... | ASPIRIN, BIVALIRUDIN, THROMBOPLASTIN, TICAGRELOR | DrugsGivenReaction | CC BY-NC | 33161652 | 19,719,802 | 2021-02 |
What was the outcome of reaction 'Pneumonia klebsiella'? | Impella 5.0 supported oncological surgery as bridge to LVAD.
We describe the case of a 58-year-old man presenting with myocardial infarction complicated by cardiogenic shock, treated with Impella CP which was escalated to an axillary 5.0 due to lack of cardiac recovery. Weaning from Impella 5.0 failed, and the patient ... | Fatal | ReactionOutcome | CC BY-NC | 33161652 | 19,719,802 | 2021-02 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Death'. | Prediction of Stem Cell Mobilization Failure in Patients with Hodgkin and Non-Hodgkin Lymphoma
Autologous stem cell transplantation (ASCT) is a significant and potentially curative treatment modality for patients with relapsed/refractory lymphoma. Insufficient mobilization and harvest of peripheral stem cells can be a ... | FILGRASTIM | DrugsGivenReaction | CC BY | 33161684 | 19,859,879 | 2021-08-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Engraft failure'. | Prediction of Stem Cell Mobilization Failure in Patients with Hodgkin and Non-Hodgkin Lymphoma
Autologous stem cell transplantation (ASCT) is a significant and potentially curative treatment modality for patients with relapsed/refractory lymphoma. Insufficient mobilization and harvest of peripheral stem cells can be a ... | FILGRASTIM | DrugsGivenReaction | CC BY | 33161684 | 19,859,879 | 2021-08-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Lymphoma'. | Prediction of Stem Cell Mobilization Failure in Patients with Hodgkin and Non-Hodgkin Lymphoma
Autologous stem cell transplantation (ASCT) is a significant and potentially curative treatment modality for patients with relapsed/refractory lymphoma. Insufficient mobilization and harvest of peripheral stem cells can be a ... | FILGRASTIM | DrugsGivenReaction | CC BY | 33161684 | 19,859,879 | 2021-08-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapy partial responder'. | Prediction of Stem Cell Mobilization Failure in Patients with Hodgkin and Non-Hodgkin Lymphoma
Autologous stem cell transplantation (ASCT) is a significant and potentially curative treatment modality for patients with relapsed/refractory lymphoma. Insufficient mobilization and harvest of peripheral stem cells can be a ... | FILGRASTIM | DrugsGivenReaction | CC BY | 33161684 | 19,859,879 | 2021-08-25 |
What was the dosage of drug 'FILGRASTIM'? | Prediction of Stem Cell Mobilization Failure in Patients with Hodgkin and Non-Hodgkin Lymphoma
Autologous stem cell transplantation (ASCT) is a significant and potentially curative treatment modality for patients with relapsed/refractory lymphoma. Insufficient mobilization and harvest of peripheral stem cells can be a ... | 10 MICROGRAM/KILOGRAM | DrugDosageText | CC BY | 33161684 | 19,859,879 | 2021-08-25 |
What was the outcome of reaction 'Death'? | Prediction of Stem Cell Mobilization Failure in Patients with Hodgkin and Non-Hodgkin Lymphoma
Autologous stem cell transplantation (ASCT) is a significant and potentially curative treatment modality for patients with relapsed/refractory lymphoma. Insufficient mobilization and harvest of peripheral stem cells can be a ... | Fatal | ReactionOutcome | CC BY | 33161684 | 19,859,879 | 2021-08-25 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypothyroidism'. | A Durable Response after the Discontinuation of Nivolumab in an Advanced Gastric Cancer Patient.
A durable response after the discontinuation of immune checkpoint-inhibitor therapy has previously been reported in several cancers. We herein describe a patient with gastric cancer who maintained a durable response after t... | CAPECITABINE, GIMERACIL\OTERACIL\TEGAFUR, IRINOTECAN, NIVOLUMAB, OXALIPLATIN, PACLITAXEL, RAMUCIRUMAB | DrugsGivenReaction | CC BY-NC-ND | 33162479 | 19,477,673 | 2021-04-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Secondary adrenocortical insufficiency'. | A Durable Response after the Discontinuation of Nivolumab in an Advanced Gastric Cancer Patient.
A durable response after the discontinuation of immune checkpoint-inhibitor therapy has previously been reported in several cancers. We herein describe a patient with gastric cancer who maintained a durable response after t... | CAPECITABINE, GIMERACIL\OTERACIL\TEGAFUR, IRINOTECAN, NIVOLUMAB, OXALIPLATIN, PACLITAXEL, RAMUCIRUMAB | DrugsGivenReaction | CC BY-NC-ND | 33162479 | 19,477,673 | 2021-04-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Thyroiditis'. | A Durable Response after the Discontinuation of Nivolumab in an Advanced Gastric Cancer Patient.
A durable response after the discontinuation of immune checkpoint-inhibitor therapy has previously been reported in several cancers. We herein describe a patient with gastric cancer who maintained a durable response after t... | CAPECITABINE, GIMERACIL\OTERACIL\TEGAFUR, IRINOTECAN, NIVOLUMAB, OXALIPLATIN, PACLITAXEL, RAMUCIRUMAB | DrugsGivenReaction | CC BY-NC-ND | 33162479 | 19,477,673 | 2021-04-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Treatment failure'. | A Durable Response after the Discontinuation of Nivolumab in an Advanced Gastric Cancer Patient.
A durable response after the discontinuation of immune checkpoint-inhibitor therapy has previously been reported in several cancers. We herein describe a patient with gastric cancer who maintained a durable response after t... | CAPECITABINE, GIMERACIL\OTERACIL\TEGAFUR, IRINOTECAN, NIVOLUMAB, OXALIPLATIN, PACLITAXEL, RAMUCIRUMAB | DrugsGivenReaction | CC BY-NC-ND | 33162479 | 19,477,673 | 2021-04-01 |
What was the outcome of reaction 'Hypothyroidism'? | A Durable Response after the Discontinuation of Nivolumab in an Advanced Gastric Cancer Patient.
A durable response after the discontinuation of immune checkpoint-inhibitor therapy has previously been reported in several cancers. We herein describe a patient with gastric cancer who maintained a durable response after t... | Recovering | ReactionOutcome | CC BY-NC-ND | 33162479 | 19,477,673 | 2021-04-01 |
What was the outcome of reaction 'Secondary adrenocortical insufficiency'? | A Durable Response after the Discontinuation of Nivolumab in an Advanced Gastric Cancer Patient.
A durable response after the discontinuation of immune checkpoint-inhibitor therapy has previously been reported in several cancers. We herein describe a patient with gastric cancer who maintained a durable response after t... | Recovering | ReactionOutcome | CC BY-NC-ND | 33162479 | 19,477,673 | 2021-04-01 |
What was the outcome of reaction 'Thyroiditis'? | A Durable Response after the Discontinuation of Nivolumab in an Advanced Gastric Cancer Patient.
A durable response after the discontinuation of immune checkpoint-inhibitor therapy has previously been reported in several cancers. We herein describe a patient with gastric cancer who maintained a durable response after t... | Recovering | ReactionOutcome | CC BY-NC-ND | 33162479 | 19,477,673 | 2021-04-01 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'JC virus infection'. | Early Pathological JC Virus Lesions in a Patient without Any MRI-based Indications.
A 70-year-old woman with a human T-cell leukemia virus type 1 infection without any focal neurological symptoms showed age-related atherosclerotic changes in the white matter without any suspicious signal changes suggestive of progressi... | CYCLOSPORINE, PREDNISOLONE | DrugsGivenReaction | CC BY-NC-ND | 33162483 | 19,962,956 | 2021-04-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pneumonia'. | Early Pathological JC Virus Lesions in a Patient without Any MRI-based Indications.
A 70-year-old woman with a human T-cell leukemia virus type 1 infection without any focal neurological symptoms showed age-related atherosclerotic changes in the white matter without any suspicious signal changes suggestive of progressi... | CYCLOSPORINE, PREDNISOLONE | DrugsGivenReaction | CC BY-NC-ND | 33162483 | 19,962,956 | 2021-04-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Progressive multifocal leukoencephalopathy'. | Early Pathological JC Virus Lesions in a Patient without Any MRI-based Indications.
A 70-year-old woman with a human T-cell leukemia virus type 1 infection without any focal neurological symptoms showed age-related atherosclerotic changes in the white matter without any suspicious signal changes suggestive of progressi... | CYCLOSPORINE, PREDNISOLONE | DrugsGivenReaction | CC BY-NC-ND | 33162483 | 19,962,956 | 2021-04-15 |
What was the outcome of reaction 'JC virus infection'? | Early Pathological JC Virus Lesions in a Patient without Any MRI-based Indications.
A 70-year-old woman with a human T-cell leukemia virus type 1 infection without any focal neurological symptoms showed age-related atherosclerotic changes in the white matter without any suspicious signal changes suggestive of progressi... | Not recovered | ReactionOutcome | CC BY-NC-ND | 33162483 | 19,962,956 | 2021-04-15 |
What was the outcome of reaction 'Pneumonia'? | Early Pathological JC Virus Lesions in a Patient without Any MRI-based Indications.
A 70-year-old woman with a human T-cell leukemia virus type 1 infection without any focal neurological symptoms showed age-related atherosclerotic changes in the white matter without any suspicious signal changes suggestive of progressi... | Fatal | ReactionOutcome | CC BY-NC-ND | 33162483 | 19,962,956 | 2021-04-15 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.